Press Releases

NANAIMO, British Columbia --(BUSINESS WIRE)--Oct. 31, 2018-- Tilray, Inc. (“ Tilray” or the “Company”) (NASDAQ: TLRY), a global leader in cannabis production and distribution, today announced that Brendan Kennedy , President and Chief Executive Officer, and Mark Castaneda , Chief Financial Officer,

NANAIMO, British Columbia --(BUSINESS WIRE)--Oct. 30, 2018-- Tilray Inc. (Nasdaq: TLRY), a global leader in cannabis production and distribution, announced today it will report results for the third quarter ended September 30, 2018 on Tuesday, November 13, 2018 after market close.

NANAIMO, British Columbia --(BUSINESS WIRE)--Oct. 10, 2018-- Tilray, Inc. (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced that it has closed its offering of 5.00% Convertible Senior Notes due 2023 (the “notes”) for gross proceeds of 

NANAIMO, British Columbia & SANTIAGO, Chile --(BUSINESS WIRE)--Oct. 9, 2018-- Tilray, Inc. (NASDAQ: TLRY), a global leader in cannabis research and production, today announced that it has completed an acquisition of its existing import and distribution partner Alef Biotechnology SpA (“Alef”).

NANAIMO, British Columbia --(BUSINESS WIRE)--Oct. 4, 2018-- Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced the pricing of US$450 million aggregate principal amount of Convertible Senior Notes due 2023 (the “notes”) in a

NANAIMO, British Columbia --(BUSINESS WIRE)--Oct. 3, 2018-- Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced that it intends to offer, subject to market conditions and other factors, $400 million aggregate principal amount of

TORONTO --(BUSINESS WIRE)--Oct. 1, 2018-- High Park Farms™ Ltd., a subsidiary of Tilray, Inc. (NASDAQ: TLRY), announced today that it has received its sales license from Health Canada to sell cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR).

Tilray CBD 100 Product Successfully Exported to Victoria, Australia and Will Be Supplied to Additional Pediatric Patients NANAIMO, British Columbia --(BUSINESS WIRE)--Sep. 24, 2018-- Tilray, Inc . (NASDAQ: TLRY), a global pioneer in cannabis production and distribution, today announced that it has

U.S. Drug Enforcement Administration approves import of a pharmaceutical-grade medical cannabis product produced by Tilray into the United States for a clinical trial focused on Essential Tremor NANAIMO, British Columbia --(BUSINESS WIRE)--Sep. 18, 2018-- Tilray Inc.

Tilray becomes first and only company with both flower and oil medical cannabis products available in the German market NANAIMO, British Columbia --(BUSINESS WIRE)--Sep. 13, 2018-- Tilray, Inc ., (NASDAQ: TLRY), a global leader in cannabis research, cultivation, production and distribution, today